期刊文献+

氨基末端脑钠肽前体在急性ST段抬高型心肌梗死急诊PCI术后患者中的临床意义 被引量:10

Clinical significance of N-terminal brain natriuretic peptide in acute ST-segment elevation myocardial infarction patients of having reveived emergency percutaneous coronary intervention
暂未订购
导出
摘要 目的评价急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)术后血浆氨基末端脑钠肽前体(NT-proBNP)水平的临床意义。方法选择207例发病24 h之内进行急诊PCI的STEMI患者,采用荧光免疫抗原抗体结合方法测定术后入院即时血浆NT-proBNP水平,收集年龄、左室射血分数(LVEF)、入院时心功能(killip分级)、发病至梗死相关血管开通时间等临床资料,并根据相应程度或等级分组,对比各组间NT-proBNP水平的差异。结果 NT-proBNP水平与年龄呈正相关(r=0.39,P=0.000),与LVEF呈负相关(r=-0.29,P=0.000);入院时killip分级Ⅲ~Ⅳ级组和Ⅱ级组NT-proBNP水平高于I级组(P均<0.01);随着STEMI患者梗死相关血管开通时间的延迟,NT-proBNP水平依次增高(P均<0.01)。结论 STEMI患者PCI术后血浆NT-proBNP水平与年龄、LVEF、killip分级、发病至梗死相关血管开通时间相关。 Objective To evaluate the clinical significance of N-terminal brain natriuretic peptide(NT-proBNP) in acute ST-segment elevation myocardial infarction(STEMI) patients of having reveived emergency percutaneous coronary intervention(PCI).Methods A total of 207 patients had diagnosed as acute STEMI and had reveived emergency PCI within 24 hours since the symptoms occurred were included.We detected the plasma NT-proBNP level immediately after emergency PCI with immunofluorescence technic,collected clinical data during hospitalization,including admission age,Killip classification of cardiac function,left ventricular ejection fraction(LVEF) in cardiac ultrasonography,duration from onset to patency of diseased vessels,and then divided the patients into several subgroups according these data and analyzed the difference of NT-proBNP among the subgroups.Results Plasma NT-proBNP level had a positive correlation with age(r=0.39,P=0.000),and negative correlation with LVEF(r=-0.29,P=0.000);Plasma NT-proBNP level in Killip Ⅲ-Ⅳ and Ⅱ subgroup were higher than Killip Ⅰ subgroup(P〈0.01);Plasma NT-proBNP level increased as the patency time of infarct related artery prolonged(P〈0.01).Conclusion Plasma NT-proBNP levels in acute STEMI patients who received emergency PCI are related to patients' age,LVEF,Killip classfication of cardiac function,and the patent time of criminal vessels.
出处 《山东医药》 CAS 2012年第4期19-21,共3页 Shandong Medical Journal
关键词 氨基末端脑钠肽前体 急性心肌梗死 经皮冠状动脉介入治疗 N-terminal brain natriuretic peptide ST-segment elevation myocardial infarction percutaneous coronary intervention
  • 相关文献

参考文献13

  • 1温绍君,王耀宏,王卫梅,房芳,文杰,王金城,张忱,张维君,左大鹏.心脏病患者心功能与心包液中心钠素和内皮素浓度的关系[J].中华心血管病杂志,2000,28(5):377-378. 被引量:15
  • 2Clerico A, Fontana M, Zyw L, et al. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review [J]. Clin Chem, 2007,53(5) :813-822.
  • 3de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [ J ]. N Engl J Med, 2001,345 (14) : 1014-1021.
  • 4Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natriurtic peptide levels for dynamic risk stratification of patients with acute coronary syndromes [ J ]. Circulation, 2004, 110 ( 20 ) : 3206-3212.
  • 5Galvani M, Ottani F, Ohrona L, et al. N-terminal pro-brain natri-uretic on admission has prognostic value across the whole spectrum of acute coronary syndromes [ J ]. Circulation, 2004, 110 ( 2 ) : 128-134.
  • 6Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction. B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 [J]. J Am Coil Cardiol, 2003,41 (8) : 1264 -1272.
  • 7Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure [J]. Clin Chem Lab Med, 2001,39(7) :571-588.
  • 8Muellcr C, Breidthardt T, Laule-Kilian K, et al. The integration of BNP and NT-proBNP into clinical medicine [ J]. Swiss Med Wkly, 2007,137 (1-2) :4-12.
  • 9Weber M, Dill T, Arnold R, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris [J]. Am Heart J, 2004,148(4) :612-620.
  • 10Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia [ J ]. J Am Coil Cardiol, 2004,44 (10) : 1988-1995.

二级参考文献13

  • 1张维君,温绍君,刘裕,陈宝田,何士大,洪敏,胡旭东.人类心包心钠素基因转录和表达[J].中华心血管病杂志,1996,24(1):49-51. 被引量:5
  • 2Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (VaI-HeFT). Circulation, 2003, 107 : 1278-1283.
  • 3Maurellet JD, Liu PT. B-type natriuretic peptide in the management of heart failure. Hong Kong Med J, 2008,14:216- 219.
  • 4Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis ,2002,44:293-321.
  • 5Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation, 1996,93 : 1963-1969.
  • 6Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B- type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation, 2004,110 : 1387-1391.
  • 7Crilley JG, Farrer M. Left ventricular remodeling and brain natriuretic peptide after first myocardial infarction. Heart, 2001, 86:638-642.
  • 8Deo R, de Lemos JA. B-type natriuretic peptide in ischemic heart disease. Curr Cardiol Rep,2003 ,5 :271-277.
  • 9Grybauskiene R, Karciauskaite D, Brazdzionyte J, et al. Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years after myocardial infarction. Medicina (Kaunas) ,2007,43:708-715.
  • 10Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J, 2003, 17: 1105-1107.

共引文献53

同被引文献375

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部